Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Aura Biosciences Inc. Common Stock
AURA | US
7.27
USD0.01
0.14%
AURA | US
Loading StockChartView...
About Aura Biosciences Inc. Common Stock
Sector
1501796
Industry
1501796
Earnings date
30/06/2024
As of date
24/04/2026
Close
7.27
Open
7.25
High
7.52
Low
7.02
Aura Biosciences Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for treating tumors of high unmet need in ocular and urologic oncology. It is developing AU-011 a VDC candidate for the treatment of primary choroidal melanoma that is in phase III clinical trial. The company also develops AU-011 for additional ocular oncology indications including choroidal metastases and is in Phase 2 dose-escalation trial. The company was incorporated in 2009 and is headquartered in Cambridge Massachusetts.
View LessAURA | US
Risk
43.1
Sharpe
0.35
Luna's Score
58/100
Recommendation
Hold
Luna says (AURA | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Smallcap (300M - 2B USD)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
41.0%1 month
43.1%3 months
55.0%6 months
54.7%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.04
Debt to equity
0.10
Debt to assets
0.09
Ent. to EBITDA
-5.68
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-89.06M
MarketCap
360.64M
MarketCap(USD)
360.64M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-45.09
Short ratio
6.95
Short perc.
3.15
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.99
Range1M
1.51
Range3M
2.81
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.94
Price X volume
2.18M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -5.68 | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | - | - |
| Price to Book | 3.04 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 55.02 | - | - |
| Debt to Equity | 0.10 | - | - |
| Debt to Assets | 0.09 | - | - |
| Market Cap | 360.64M | - | - |
